{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:30:18Z","timestamp":1759667418223},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.canlet.2007.06.001","type":"journal-article","created":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T11:25:44Z","timestamp":1184153144000},"page":"196-206","source":"Crossref","is-referenced-by-count":49,"title":["High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma"],"prefix":"10.1016","volume":"256","author":[{"given":"Norihiko","family":"Akamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Makabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Tsuruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunao","family":"Atogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimeru","family":"Kamihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2007.06.001_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1189\/jlb.72.5.856","article-title":"Interleukin 21 and IL-21 receptor: novel effector of NK and T cell responses","volume":"72","author":"Parrish-Novak","year":"2002","journal-title":"J. Leuk. Biol."},{"key":"10.1016\/j.canlet.2007.06.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","article-title":"Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex","volume":"167","author":"Asao","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib3","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.200360997","article-title":"Cloning of a type I cytokine receptor most related to the IL-2 receptor \u03b2 chain","volume":"97","author":"Ozaki","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2007.06.001_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis","volume":"173","author":"Jin","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib5","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.4049\/jimmunol.170.8.4111","article-title":"IL-21 induces the apoptosis of resting and activated primary B cells","volume":"170","author":"Mehta","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib6","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","article-title":"Regulation of B cell differentiation and plasma cell generation by IL-21, a novel induce of Blimp-1 and Bcl-6","volume":"173","author":"Ozaki","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri1688","article-title":"Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation","volume":"5","author":"Leonard","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2141.2004.05255.x","article-title":"Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells","volume":"128","author":"Ueda","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2007.06.001_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199609093442","article-title":"Features of the cytokines secreted by adult T cell leukemia cells","volume":"21","author":"Yamada","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2007.06.001_bib10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.189.7.1063","article-title":"Fas gene mutation in the progression of adult T cell leukemia","volume":"189","author":"Maeda","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2007.06.001_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0014-5793(02)03254-4","article-title":"Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli","volume":"528","author":"Asano","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2007.06.001_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.2004.05289.x","article-title":"Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand","volume":"128","author":"Hasegawa","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2007.06.001_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2007.06.001_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2007.06.001_bib15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-02-0542","article-title":"Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma","volume":"106","author":"Tagawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2007.06.001_bib16","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.177.8.5236","article-title":"Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21","volume":"177","author":"Good","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1189\/jlb.0206096","article-title":"Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21","volume":"80","author":"Jin","year":"2006","journal-title":"J. Leuk. Biol."},{"key":"10.1016\/j.canlet.2007.06.001_bib18","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood-2005-09-3535","article-title":"Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia","volume":"107","author":"de Totero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2007.06.001_bib19","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood.V99.10.3756","article-title":"Interleukin-21 is a growth and survival factor for human myeloma cells","volume":"99","author":"Brenne","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2007.06.001_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2007.06.001_bib21","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","article-title":"The role of STATs in transcriptional control and their impact on cellular function","volume":"19","author":"Bromberg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2007.06.001_bib22","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/MCB.17.9.5328","article-title":"Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis","volume":"17","author":"Chin","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2007.06.001_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0959-9673.2003.00363.x","article-title":"STAT1 a novel regulator of apoptosis","volume":"84","author":"Stephanou","year":"2003","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.canlet.2007.06.001_bib24","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.4049\/jimmunol.177.12.8381","article-title":"Identification of cellular intermediates and molecular pathways induced by IL-21 in human B cells","volume":"177","author":"Konforte","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cellsig.2005.05.015","article-title":"CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1\/2 and ERK1\/2","volume":"18","author":"Ahmed-Choudhury","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2007.06.001_bib26","doi-asserted-by":"crossref","first-page":"34547","DOI":"10.1074\/jbc.M405045200","article-title":"Jak2 tyrosine kinase mediates oxidative stress-induce apoptosis in vascular smooth muscle cells","volume":"279","author":"Sandberg","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2007.06.001_bib27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.171.2.608","article-title":"IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma","volume":"171","author":"Ma","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib28","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.172.3.1540","article-title":"IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice","volume":"172","author":"Di Carlo","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.173.2.900","article-title":"IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21","volume":"173","author":"Moroz","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2007.06.001_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1525-0016(03)00222-3","article-title":"Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma","volume":"8","author":"Kishida","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2007.06.001_bib31","doi-asserted-by":"crossref","unstructured":"W. Kindsvogel, S. Hughes, K. Bannink, M. Heipel, B. Johnson, R. Holly, et al., IL-21 enhances rituximab-mediated killing of B-lymphoma cell lines in vitro and in vivo, J. Clin. Oncol. 22 (14S) (2004) ASCO Annual Meeting Proceedings 2581.","DOI":"10.1200\/jco.2004.22.14_suppl.2581"},{"key":"10.1016\/j.canlet.2007.06.001_bib32","doi-asserted-by":"crossref","unstructured":"J.A. Thompson, B.D. Curti, B.G. Redman, J.S. Weber, S.S. Agarwala, E.L. Sievers, Interleukin-21 (IL-21): tolerability and anti-tumor activity following two 5-day cycles in patients with stage IV melanoma (MM) or renal cell carcinoma (RCC), J. Clin. Oncol. 24 (18S) (2006) ASCO Annual Meeting Proceedings 2505.","DOI":"10.1200\/jco.2006.24.18_suppl.2505"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383507002777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383507002777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T15:09:15Z","timestamp":1708096155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383507002777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0304383507002777"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2007.06.001","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}